Camson Bio Technologies share price
BSE: 538858Pharmaceuticals & Biotechnology
Camson Bio Technologies Ltd · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 2015
Trading suspended since 6 May 2021
Last traded ₹3.31 on 11 May 2020
Latest announcements
Routine notices left out.
Jan 2021
13 Jan · Management
Feb 2020
28 Feb · Corporate Insolvency Resolution Process (CIRP)-Replacement of Interim Resolution Professional (IRP)
Nov 2019
Oct 2019
Q1 results, quarter to Jun 2019
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
- RevenueRevenue from operations. Money earned from selling the company's goods and services in the period. Revenue from operations in the glossary
- ₹1.19 Cr−8.1% on a year ago · +101.7% on the quarter beforeChange on a year ago and on the quarter before. The change against the same quarter a year before: (this quarter's figure less that quarter's) divided by that quarter's, times 100. The change on the quarter before is the same sum against the quarter just before, taken as this quarter's results restate it where the company restated it: this quarter's year to date less this quarter. Left out where either figure is a loss, where the restatement covers two or more earlier quarters without saying which, or across a change of basis named under the table, on the lines it affects.
- Operating profitOperating profit before depreciation (EBITDA). Revenue less operating expenses: what the business earns from its operations before depreciation, interest and tax. Operating profit before depreciation (EBITDA) in the glossary
- −₹5.53 Cr
- Net profitNet profit. What is left of revenue and other income after every cost, interest and tax. Net profit in the glossary
- −₹7.54 Cr
- Earnings per shareEarnings per share. Profit belonging to shareholders divided by the number of shares, restated for later splits and bonuses so they do not break the line. Earnings per share in the glossary
- −₹2.51
- Operating margin
- −466.8%
- Net margin
- −636.4%
From revenue to net profit, ₹ crore
- Revenue1.2
- Materials and goods−5.4
- Employee costs−0.6
- Other expenses−0.7
- Operating profit−5.5
- Depreciation−1.7
- Other income0.0
- Finance costs−0.3
- Profit before tax−7.5
- Tax0.0
- Net profit−7.5
Camson Bio Technologies results by quarter
Standalone: the listed company alone, without its subsidiaries. Latest quarter to Jun 2019. Results for the quarter to Sep 2019 were due by 14 Nov 2019, 45 days after it ends. Every company's dates are on the results calendar.
Revenue and net profit by quarter, ₹ crore
- Revenue
- Net profit
- Loss
Peak revenue ₹11 Cr, quarter to Jun 2017; lowest −₹0.51 Cr, quarter to Mar 2018A loss in 11 of the 12 quarters shown
Operating and net margin by quarter, per cent
- Operating margin
- Net margin
| ₹ crore | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018Q1 | Sep 2018 | Dec 2018Q3 | Mar 2019 | Jun 2019Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 54.6 | 37.5 | 18.6 | 12.3 | 4.5 | – | 2.1 | 2.2 | 5.4 | 0.7 | 11.3 | 4.7 | 3.9 | −0.5 | 1.3 | 1.5 | 1.6 | 0.6 | 1.2 |
| Operating expenses. What the business spent to run itself in the period, materials, staff and other costs, before depreciation, interest and tax. Operating expenses in the glossary | 47.0 | 40.7 | 13.2 | 10.2 | 10.6 | – | 6.3 | 5.2 | 5.5 | 10.7 | 7.1 | 4.9 | 4.8 | 2.5 | 1.8 | 2.9 | 1.2 | 15.4 | 6.7 |
| Materials and goods boughtCost of materials and goods. Raw materials used and goods bought for resale in the period, adjusted for the change in stock held. Cost of materials and goods in the glossary | 25.9 | 22.5 | 3.1 | 0.8 | 0.6 | – | 0.9 | 0.8 | 1.4 | −0.7 | 4.2 | 1.6 | 1.3 | 0.6 | 0.6 | 1.1 | −0.3 | 13.8 | 5.4 |
| Employee costsEmployee costs. Salaries, wages, bonuses and other benefits paid to staff in the period. Employee costs in the glossary | – | – | – | – | – | – | – | – | – | 1.4 | 1.4 | 1.3 | 1.2 | 1.2 | 0.8 | 0.8 | 0.7 | 0.7 | 0.6 |
| Other expensesOther expenses. Every operating cost besides materials and staff: power, rent, freight, repairs, marketing and the like. Other expenses in the glossary | – | – | – | – | – | – | – | – | – | 10.0 | 1.5 | 2.0 | 2.3 | 0.7 | 0.5 | 1.0 | 0.8 | 0.9 | 0.7 |
| Operating profit before depreciation | 7.6 | −3.2 | 5.4 | 2.1 | −6.1 | – | −4.3 | −3.0 | −0.1 | −9.9 | 4.2 | −0.2 | −1.0 | −3.0 | −0.6 | −1.4 | 0.3 | −14.8 | −5.5 |
| Operating margin | 13.8% | −8.6% | 29.2% | 16.9% | −134.2% | – | −208.7% | −136.6% | −2.7% | −1,372.8% | 37.0% | −3.8% | −25.4% | 585.0% | −43.3% | −90.9% | 21.6% | −2,516.5% | −466.8% |
| Depreciation and amortisationDepreciation and amortisation. The part of the cost of plant, buildings and other long-lived assets charged against each year they are used. Depreciation and amortisation in the glossary | 3.4 | 3.3 | 3.1 | 2.7 | 2.4 | – | 1.9 | 1.9 | 1.9 | 1.8 | 1.8 | 1.8 | 1.8 | 1.7 | 1.7 | 1.8 | 1.8 | 1.7 | 1.7 |
| Other incomeOther income. Income from outside the main business, such as interest on deposits, dividends received and gains on investments. Other income in the glossary | 0.3 | 5.9 | 0.1 | 0.8 | 0.0 | – | 0.5 | 0.6 | 0.6 | 2.2 | 0.7 | 0.6 | 0.2 | −0.2 | 0.0 | 0.1 | 2.3 | 0.8 | 0.0 |
| Finance costsFinance costs. Interest and the other costs of borrowing in the period. Finance costs in the glossary | 0.7 | 1.6 | 1.0 | 1.2 | 1.2 | – | 1.1 | 1.0 | 2.5 | 1.9 | 1.2 | 1.2 | 3.0 | −0.1 | 1.7 | 2.3 | 2.1 | −5.0 | 0.3 |
| One-off itemsExceptional items. Gains or losses the company reports separately because they are not expected to recur, such as selling a business or writing down an asset. Exceptional items in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit before tax | 3.8 | −2.3 | 1.4 | −1.0 | −9.7 | – | −6.7 | −5.3 | −3.9 | −11.4 | 1.8 | −2.6 | −5.6 | −4.9 | −4.0 | −5.3 | −1.2 | −10.7 | −7.5 |
| 1.8 | 0.9 | 0.6 | −0.4 | 0.4 | – | 0.2 | 0.2 | −0.4 | −0.1 | – | – | – | – | 0.2 | 0.3 | −0.6 | 0.6 | 0.0 | |
| Tax rateEffective tax rate. Tax charged as a percentage of profit before tax. Effective tax rate in the glossary | 48.5% | – | 44.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Net profit | 2.0 | −3.1 | 0.8 | −0.6 | −10.1 | – | −6.9 | −5.5 | −3.5 | −11.3 | 1.8 | −2.6 | −5.6 | −4.9 | −4.3 | −5.7 | −0.6 | −11.3 | −7.5 |
| Net margin | 3.6% | −8.4% | 4.2% | −5.1% | −223.0% | – | −337.0% | −249.8% | −65.2% | −1,561.5% | 16.2% | −54.3% | −144.9% | 963.3% | −330.4% | −374.3% | −41.0% | −1,922.5% | −636.4% |
| Earnings per share | – | – | – | – | – | – | – | – | −₹1.17 | −₹3.77 | ₹0.61 | −₹0.85 | −₹1.86 | −₹1.63 | −₹1.42 | −₹1.90 | −₹0.22 | −₹3.77 | −₹2.51 |
Earnings per share in rupees, restated for later splits and bonuses. No results on record for the quarter to Mar 2016.
The quarters either side of a change of basis do not compare. From the quarter to Sep 2015, part of the business was demerged on 21 Sep 2015, and figures before the change include the part that left.
5 years at a glance
Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.
Revenue, net profit and borrowings, ₹ crore
- Revenue
- Net profit
- Borrowings
- Loss
A loss in 3 of the 4 years with results on record
Operating and net margin, per cent
- Operating marginOperating margin. Operating profit before depreciation as a percentage of revenue: how much of each rupee of sales is left after running costs. Operating margin in the glossary
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
The years either side of a change of basis do not compare. From the year to Mar 2016, part of the business was demerged on 21 Sep 2015, and figures before the change include the part that left.
Results for the year to Mar 2019
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
From revenue to net profit
- Revenue5.0
- Materials and goods−15
- Employee costs−3.0
- Other expenses−3.2
- Operating profit−16
- Depreciation−7.0
- Other income+3.2
- One-off items0.0
- Finance costs−1.1
- Profit before tax−21
- Tax−0.6
- Net profit−22
What the company owns
- Plant, investments and other assets₹90 Cr
- Inventory₹26 Cr
- Receivables₹15 Cr
- Cash and bank₹0 Cr
What pays for it: net worth and liabilities
- Borrowings₹50 Cr
- Net worth₹45 Cr
- Other liabilities₹29 Cr
- Owed to suppliers₹8 Cr
Profit and loss
Standalone, ₹ crore, years to March. No results on record for the year to Mar 2016. The last column is the twelve months to Jun 2019, the latest four quarters added.
| ₹ crore | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Jun 2019Twelve months |
|---|---|---|---|---|---|---|
| Revenue from operations | 169 | – | 10 | 19 | 5 | 5 |
| 153 | – | 28 | 19 | 21 | 26 | |
| Materials and goods bought | 76 | – | 2 | 8 | 15 | 20 |
| Employee costs | – | – | 6 | 5 | 3 | 3 |
| Other expenses | – | – | 19 | 7 | 3 | 3 |
| Operating profit before depreciation | 16 | – | −17 | 0 | −16 | −21 |
| Operating margin | 9.6% | – | −167.7% | 0.2% | −329.4% | −438.5% |
| Materials, % of revenueMaterials, % of revenue. Raw materials used and goods bought for resale, adjusted for the change in stock, divided by revenue, times 100. Materials, % of revenue in the glossary | – | – | 23.9% | 39.9% | 305.0% | 411.6% |
| Employee costs, % of revenueEmployee costs, % of revenue. Salaries, wages and other staff costs divided by revenue, times 100. Employee costs, % of revenue in the glossary | – | – | 56.3% | 26.1% | 59.4% | 57.2% |
| Other expenses, % of revenueOther expenses, % of revenue. Operating costs besides materials and staff divided by revenue, times 100; with the two above and the operating margin it makes 100. Other expenses, % of revenue in the glossary | – | – | 187.5% | 33.8% | 65.0% | 69.8% |
| Depreciation and amortisation | 13 | – | 7 | 7 | 7 | 7 |
| Operating profit after depreciationOperating profit after depreciation (EBIT). Operating profit before depreciation, less depreciation and amortisation. Operating profit after depreciation (EBIT) in the glossary | 3 | – | −25 | −7 | −23 | −28 |
| Other income | 6 | – | 4 | 1 | 3 | 3 |
| Finance costs | 4 | – | 7 | 5 | 1 | 0 |
| One-off items | – | – | – | – | 0 | 0 |
| Profit before tax | 5 | – | −27 | −11 | −21 | −25 |
| 2 | – | 0 | – | 1 | 0 | |
| Net profit | 3 | – | −27 | −11 | −22 | −25 |
| Net margin | 1.8% | – | −262.8% | −58.1% | −440.0% | −516.8% |
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2015 they do not, so they are left blank.
Balance sheet
Standalone, ₹ crore, at 31 March.
| ₹ crore | Mar 2019 |
|---|---|
| Net worth. What the company owns less everything it owes: the money shareholders have in the business, paid in and kept from profits. Net worth in the glossary | 45 |
| Share capitalShare capital. The face value of all the shares the company has issued. Share capital in the glossary | 30 |
| ReservesReserves. The rest of the shareholders' net worth: profits kept in the business over the years, and money paid for shares above their face value. Reserves in the glossary | 15 |
| Borrowings. Loans, bonds and other money the company has borrowed and must repay with interest. Borrowings in the glossary | 50 |
| Liabilities due within a year. Everything the company must pay within twelve months: borrowings falling due, suppliers, and other dues and provisions. Liabilities due within a year in the glossary | 73 |
| Liabilities due after a year. Everything the company owes that falls due more than twelve months on, borrowings among it. Liabilities due after a year in the glossary | 13 |
| Total assetsTotal assets. Everything the company owns or controls: plant, investments, stock, money owed by customers and cash. Total assets in the glossary | 131 |
| Assets held for longer than a year. Everything the company owns that it does not expect to turn into cash within twelve months: plant, intangibles, long-term investments, loans given and the like. Assets held for longer than a year in the glossary | 87 |
| Assets turning to cash within a year. Everything the company expects to turn into cash or use up within twelve months: stock, money owed by customers, cash and short-term investments. Assets turning to cash within a year in the glossary | 44 |
| Net debtNet debt. Borrowings less cash, other bank balances and current investments: what the company would still owe if it used its cash to repay. Net debt in the glossary | 50 |
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2015, Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.
Ratios
Standalone, years to March.
| Ratio | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 |
|---|---|---|---|---|---|
| Revenue growthRevenue growth. This year's revenue less last year's, divided by last year's, times 100; blank where last year's is not above nought. Revenue growth in the glossary | – | – | – | 86.6% | −74.2% |
| Return on equityReturn on equity. Profit belonging to shareholders as a percentage of their average net worth over the year. | – | – | – | – | −48.9%what Return on equity, Mar 2019, includes. This year's return on equity, asset turnover and assets per rupee of net worth are on its year-end balance sheet: none a year before is on record to average with. |
| Return on capital employedReturn on capital employed. Operating profit after depreciation divided by net worth plus borrowings at the year end, times 100: what the business earns on all the money in it. | – | – | – | – | −24.7% |
| Interest coverInterest cover. Operating profit after depreciation divided by finance costs: how many times over the profit pays the interest bill. Interest cover in the glossary | 0.7 | – | – | – | – |
| Debt to equityDebt to equity. Borrowings at the year end divided by net worth: rupees borrowed for each rupee shareholders have in the business. | – | – | – | – | 1.11 |
| Receivable daysReceivable days. Trade receivables divided by revenue, times 365: the average days customers take to pay. Receivable days in the glossary | – | – | – | – | 1,134 |
| Inventory daysInventory days. Inventories divided by the cost of materials and goods, times 365: the days of stock the company holds. Inventory days in the glossary | – | – | – | – | 622 |
| Payable daysPayable days. Trade payables divided by the cost of materials and goods, times 365: the average days the company takes to pay suppliers. Payable days in the glossary | – | – | – | – | 183 |
| Cash conversion cycle, daysCash conversion cycle. Receivable days plus inventory days less payable days: how long money is tied up between paying suppliers and being paid by customers. Cash conversion cycle in the glossary | – | – | – | – | 1,574 |
| Working capital daysWorking capital days. Assets turning to cash within a year, less cash, bank deposits and current investments, minus liabilities due within a year, less borrowings, divided by the year's revenue, times 365. Working capital days in the glossary | – | – | – | – | 687 |
| Asset turnoverAsset turnover. Revenue divided by average total assets: rupees of sales for each rupee of assets. Asset turnover in the glossary | – | – | – | – | 0.04 |
| Assets per rupee of net worthAssets per rupee of net worth. Average total assets divided by average net worth: how far borrowings and other liabilities stretch the shareholders' money. Assets per rupee of net worth in the glossary | – | – | – | – | 2.93 |
| Sales per rupee of plantSales per rupee of plant. Revenue divided by the net block: rupees of sales for each rupee of plant in use. Sales per rupee of plant in the glossary | – | – | – | – | 0.06 |
Interest cover is left blank for the years to Mar 2017, Mar 2018 and Mar 2019: operating profit after depreciation is a loss, and a loss covers no interest bill. No balance sheet is on record for the years to Mar 2015, Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.
Growth and returns over 3, 5 and 10 years
Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2019.
- Return on assets, latest yearReturn on assets, latest year. Profit to the company's own shareholders in the latest year ÷ the average of that year's opening and closing total assets × 100; empty for a bank, a lender or an insurer, whose own return on assets is shown with its accounts.
- −16.7%
| Measure | 5 years | 3 years |
|---|---|---|
| Operating margin, averageOperating margin, average. 3 years: The plain average of the yearly operating profit margin over the last three years, needing at least two of them; a year without the figure is left out, never filled in. 5 years: The plain average of the yearly operating profit margin over the last five years, needing at least four of them; a year without the figure is left out, never filled in. 10 years: The plain average of the yearly operating profit margin over the last ten years, needing at least nine of them; a year without the figure is left out, never filled in. | −121.8% | −165.6% |
| Net margin, averageNet margin, average. 3 years: The plain average of the yearly net profit margin over the last three years, needing at least two of them; a year without the figure is left out, never filled in. 5 years: The plain average of the yearly net profit margin over the last five years, needing at least four of them; a year without the figure is left out, never filled in. 10 years: The plain average of the yearly net profit margin over the last ten years, needing at least nine of them; a year without the figure is left out, never filled in. | −189.8% | −253.6% |
Accounting checks
Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.
| Check | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 |
|---|---|---|---|---|---|
| Altman Z-scoreAltman Z-score. Working capital, reserves, operating profit, market value and sales, each over total assets, weighted and added: a published measure of financial strain. Altman Z-score in the glossaryPublished threshold 1.81 | – | – | – | – | −0.43 |
| Effective tax ratePublished threshold 17.16 per cent | 38.94 | – | – | – | – |
A threshold marked as ours has no published figure; it is the line we read the check against.
Business segments
In the year to Mar 2019 the company reports one business segment, AGRI BIOTECH PRODUCTS, which carries all its revenue.
Where the return came from
Yearly rates to Mar 2019, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −54.5% | – | – | 0.0% |
| 3 years | −41.8% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.
Camson Bio Technologies share price by year
Each calendar year to 2020.
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2020 | 3.31 | −26.0% | 4.39 | 3.31 |
| 2019 | 4.47 | −51.9% | 13.79 | 4.47 |
| 2018 | 9.30 | −62.0% | 25.35 | 4.81 |
| 2017 | 24.50 | −4.9% | 33.50 | 16.00 |
| 2016 | 25.75 | −39.1% | 61.50 | 18.70 |
| 2015 | 42.25 | – | 132.40 | 38.85 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The 2020 close is its last trade, on 11 May 2020.
Recent sessions
The 10 trading days to 11 May 2020, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 11 May 2020 | 3.31 | 3.31 | 3.31 | 3.31 | 3.31 | 1,760 |
| 4 May 2020 | 3.37 | 3.37 | 3.37 | 3.37 | 3.37 | 261 |
| 20 Apr 2020 | 3.43 | 3.43 | 3.43 | 3.43 | 3.43 | 1,382 |
| 13 Apr 2020 | 3.50 | 3.50 | 3.50 | 3.50 | 3.50 | 1,100 |
| 7 Apr 2020 | 3.57 | 3.57 | 3.57 | 3.57 | 3.57 | 1,650 |
| 30 Mar 2020 | 3.71 | 3.71 | 3.64 | 3.64 | 3.69 | 894 |
| 16 Mar 2020 | 3.71 | 3.71 | 3.71 | 3.71 | 3.71 | 18,000 |
| 9 Mar 2020 | 3.78 | 3.78 | 3.78 | 3.78 | 3.78 | 66 |
| 2 Mar 2020 | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 30,218 |
| 24 Feb 2020 | 3.99 | 3.99 | 3.92 | 3.92 | 3.99 | 303 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 21 Sep 2015 | Demerger | 0.9815 | Part of the business became a separate company. The factor is the opening price on the ex-date divided by the previous close. The chart shows earlier prices with the demerger reinvested. |
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout.
Company details
- BSE code
- 538858
- ISIN
- INE845E01012
- Industry
- Pharmaceuticals & Biotechnology
- CIN
- L85110KA1993PLC014944
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1993
- Registered office
- C-7, Corporate Block, Golden Enclave, 7th Floor, Old Airport Road, Bengaluru 560017, Karnataka
- Share registrar
- Integrated Enterprises (India) Ltd
- Keeps the register of shareholders and handles transfers and dividend payments